Metabolic remodeling and cardiac dysfunction in left ventricular noncompaction: Insights from the MYH7 Q315R model. [PDF]
Takarada S +21 more
europepmc +1 more source
Mutation of p53 Acetylation Protects Against Angiotensin-II-Induced Cardiac Dysfunction and Fibrosis. [PDF]
Cantrell AC +3 more
europepmc +1 more source
MiR-143-5p serves as a diagnostic biomarker in patients with sepsis and regulates sepsis-induced inflammation and cardiac dysfunction. [PDF]
Wu Y, Gu L, Huang X.
europepmc +1 more source
LARP1 acts as a key mediator in preventing angiotensin II-induced cardiac dysfunction and fibrosis. [PDF]
Zheng H, Yang C.
europepmc +1 more source
Loss of Elmsan1 in cardiomyocytes leads to age-dependent cardiac dysfunction and reduced lifespan. [PDF]
Wang M +12 more
europepmc +1 more source
Dietary Nitrate Prevents Cardiac Dysfunction in HFrEF by Improving Hemodynamics, Ameliorating Remodeling, and Resolving Inflammation. [PDF]
Shimari M +9 more
europepmc +1 more source
Related searches:
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Ca-A Cancer Journal for Clinicians, 2016Giuseppe Curigliano +2 more
exaly

